These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21286014)

  • 1. GSTM1 tissue genotype as a recurrence predictor in non-muscle invasive bladder cancer.
    Ha YS; Yan C; Jeong P; Kim WT; Yun SJ; Kim IY; Moon SK; Kim WJ
    J Korean Med Sci; 2011 Feb; 26(2):231-6. PubMed ID: 21286014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSTT1 as a prognosticator for recurrence and progression in patients with non-muscle-invasive bladder cancer.
    Ha YS; Yan C; Lym MS; Jeong P; Kim WT; Kim YJ; Yun SJ; Lee SC; Moon SK; Choi YH; Kim WJ
    Dis Markers; 2010; 29(2):81-7. PubMed ID: 21045267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility and outcomes in muscle invasive bladder cancer patients.
    Kang HW; Song PH; Ha YS; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Moon SK; Kim WJ
    Eur J Cancer; 2013 Sep; 49(14):3010-9. PubMed ID: 23810248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of GSTT1 polymorphisms in predicting the early response to induction BCG therapy in patients with non-muscle invasive bladder cancer.
    Kang HW; Tchey DU; Yan C; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YH; Kim IY; Kim WJ
    Urol Oncol; 2014 May; 32(4):458-65. PubMed ID: 24411789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic impact of GSTM1/GSTP1 genetic variants in bladder Cancer.
    Albarakati N; Khayyat D; Dallol A; Al-Maghrabi J; Nedjadi T
    BMC Cancer; 2019 Oct; 19(1):991. PubMed ID: 31646988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GSTT1: a marker of the aggressiveness of bladder cancer.
    Ha YS; Yan C; Park C; Yun SJ; Moon SK; Choi YH; Kim WJ
    Urol Int; 2011; 86(1):41-6. PubMed ID: 21079384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer.
    Kim EJ; Jeong P; Quan C; Kim J; Bae SC; Yoon SJ; Kang JW; Lee SC; Jun Wee J; Kim WJ
    Urology; 2005 Jan; 65(1):70-5. PubMed ID: 15667866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
    Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
    Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione S-transferase T1, O1 and O2 polymorphisms are associated with survival in muscle invasive bladder cancer patients.
    Djukic TI; Savic-Radojevic AR; Pekmezovic TD; Matic MG; Pljesa-Ercegovac MS; Coric VM; Radic TM; Suvakov SR; Krivic BN; Dragicevic DP; Simic TP
    PLoS One; 2013; 8(9):e74724. PubMed ID: 24040330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients.
    Sweeney C; Nazar-Stewart V; Stapleton PL; Eaton DL; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):527-33. PubMed ID: 12814998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy number variation in glutathione-S-transferase T1 and M1 predicts incidence and 5-year survival from prostate and bladder cancer, and incidence of corpus uteri cancer in the general population.
    Nørskov MS; Frikke-Schmidt R; Bojesen SE; Nordestgaard BG; Loft S; Tybjærg-Hansen A
    Pharmacogenomics J; 2011 Aug; 11(4):292-9. PubMed ID: 20514077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population.
    Törüner GA; Akyerli C; Uçar A; Aki T; Atsu N; Ozen H; Tez M; Cetinkaya M; Ozçelik T
    Arch Toxicol; 2001 Oct; 75(8):459-64. PubMed ID: 11757669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between polymorphisms in glutathione S-transferase (GSTM1 and GSTT1) and lung cancer outcome.
    Gonlugur U; Pinarbasi H; Gonlugur TE; Silig Y
    Cancer Invest; 2006; 24(5):497-501. PubMed ID: 16939958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene-Smoking Interaction.
    Lacombe L; Fradet V; Lévesque É; Pouliot F; Larue H; Bergeron A; Hovington H; Caron A; Nguile-Makao M; Harvey M; Fradet Y; Guillemette C
    Cancer Prev Res (Phila); 2016 Feb; 9(2):189-95. PubMed ID: 26645279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
    Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Gimenez-Bachs JM; Lorenzo-Romero JG; Serrano-Oviedo L; Escribano J
    BJU Int; 2011 Jun; 107(11):1825-32. PubMed ID: 20942828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione S-transferase null genotypes in transitional cell bladder cancer: a case-control study.
    Georgiou I; Filiadis IF; Alamanos Y; Bouba I; Giannakopoulos X; Lolis D
    Eur Urol; 2000 Jun; 37(6):660-4. PubMed ID: 10828664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer.
    Abdel-Rahman SZ; Anwar WA; Abdel-Aal WE; Mostafa HM; Au WW
    Cancer Detect Prev; 1998; 22(2):129-38. PubMed ID: 9544433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione S-transferase M1 gene polymorphism in bladder cancer patients. a marker for invasive bladder cancer?
    Aktas D; Ozen H; Atsu N; Tekin A; Sozen S; Tuncbilek E
    Cancer Genet Cytogenet; 2001 Feb; 125(1):1-4. PubMed ID: 11297759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.